These data starkly contrast the extreme elevations in 2-HG levels, driven by IDH mutations in gliomas; these elevations were frequent in grade 2 and 3 gliomas but infrequent in GBM (Supplementary Fig. 7c, d). The gene discussed is IDH1; the disease is central nervous system cancer.